Kiromic BioPharma, Inc.
News
Kiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14
Business Wire Kiromic BioPharma (NASDAQ: KRBP) (Kiromic or the Company), a clinical-stage, fully-integrated biotherapeutics company using its proprietary DIAMOND artificial intelligence and data mining platform to...\n more…
Kiromic BioPharma (NASDAQ:KRBP) & Cellectis (NASDAQ:CLLS) Financial Survey
Zolmax Kiromic BioPharma (NASDAQ:KRBP Get Free Report) and Cellectis (NASDAQ:CLLS Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ...\n more…
Kiromic BioPharma (NASDAQ:KRBP) Stock Price Down 6.4%
Ticker Report Shares of Kiromic BioPharma, Inc. (NASDAQ:KRBP Get Free Report) dropped 6.4% on Friday . The stock traded as low as $2.15 and last traded at $2.18. Approximately 43,486 shares were traded...\n more…
Reviewing Kiromic BioPharma (NASDAQ:KRBP) and Cellectis (NASDAQ:CLLS)
Ticker Report Kiromic BioPharma (NASDAQ:KRBP Get Free Report) and Cellectis (NASDAQ:CLLS Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, ...\n more…
Kiromic BioPharma, Inc. (NASDAQ:KRBP) Short Interest Update
Zolmax Kiromic BioPharma, Inc. (NASDAQ:KRBP Get Free Report) saw a large increase in short interest during the month of July. As of July 15th, there was short interest totalling 78,600 shares, an increase of 165.5% from the June 30th total of 29,600 shares. Based on an average daily trading volume, of 282,...\n more…